|
Manitoba

Manitoba Health, Seniors and Active Living

Set text to smallest size Set text to normal size Set text to larger size Set text to largest size
Communicable Disease Control

Communicable Disease Management Protocols

Introduction:  Purpose of the Manual

The prevention, management and control of communicable diseases requires the active participation and cooperation of all health-care professionals and practitioners.

While this manual is intended to act as a guide to the management and control of communicable diseases within the Province of Manitoba, professional judgment will still be required by those charged with providing health care services.

Protocols for specific communicable diseases contain epidemiologic information with reference to provincial and national trends. Detailed information related to laboratory testing, treatment and public health investigation is included in the protocols and reflects best practices at the time of release. As advances in scientific knowledge and health care practices become available, our collective response to well established as well as newly identified and evolving pathogens must be routinely reviewed and updated. Although the Manual will be updated periodically, practitioners must take responsibility to ensure that they have the most recent knowledge relating to the case they are dealing with and, for that reason, a list of resources has been included below.

The most current versions of the following publications:

  • Canadian Immunization Guide – Public Health Agency of Canada
  • Control of Communicable Diseases Manual – American Public Health Association
  • Principles and Practices of Infectious Diseases – Elsevier
  • Redbook: Report of the Committee on Infectious Diseases - American Academy of Pediatrics

The following organizations:

  • Infectious Diseases Society of America (Practice Guidelines)
  • Public Health Agency of Canada
  • UpToDate
  • US Centers for Disease Control and Prevention
  • US National Institutes of Health
  • World Health Organization

Most recent additions:

Protocol Anaplasmosis (May 2016) NEW
Protocol Babesiosis (May 2016) NEW
Protocol Q Fever (Coxiella burnetii) (April 2016) NEW
Protocol Cyclosporiasis (March 2016) NEW
bullet Report of Suspected Rabies Exposure (December 2015) REVISED
bullet Vaccines and Biologics Order Form (December 2015) REVISED
bullet Ebola Virus Disease (EVD) Infection Prevention and Control Interim Guidelines for PreHospital Settings (April 2015) NEW
Protocol Interim Protocol for Handling Human Remains Infected with Ebola Virus (September 2015) NEW
bullet Ebola Virus Disease (EVD) Public Health Contact Management Interim Guidelines (September 2015) REVISED
Protocol Seasonal Influenza (September 2015) REVISED
Protocol Hantavirus Pulmonary Syndrome (August 2015) REVISED
Protocol Gonorrhea (August 2015) REVISED
Protocol Legionellosis (March 2015) REVISED
Protocol Ebola Virus Disease (EVD) Interim Protocol (March 2015) REVISED
bullet Ebola Virus Disease (EVD) Infection Prevention and Control Interim Guidelines (March 2015) REVISED
bullet Ebola Virus Disease (EVD) Environmental Cleaning/Disinfection Guidelines for Community Settings (February 2015) NEW

Table of Contents

Protocols:

Click on any of the underlined letters in the yellow bar to jump to a particular topic, or hit CTRL + F to search for a keyword.

Protocol Amebiasis (February 2013)

Protocol Anaplasmosis (May 2016)

Protocol Anthrax (August 2012)

Antibiotic Resistant Organisms
         See:

Protocol Manitoba Guidelines for the Prevention and Control of Antibiotic Resistant Organisms (AROs) (January 2007)
Protocol Clostridium difficile-Associated Diseases (CDAD) (September 2006)

Protocol Babesiosis (May 2016)

Protocol Blastomycosis (September 2007)

Protocol Botulism (November 2012)

Protocol Brucellosis (November 2001)

Protocol Campylobacter Infection (February 2012)

Protocol Chancroid (November 2001)

Protocol Children with Sexually Transmitted Diseases (STDs) (November 2001)

Protocol Chlamydia trachomatis (D through K Serovars) Infection (April 2008, with August 2015 update)

Protocol Cholera (November 2001)

Protocol Clostridium difficile-Associated Diseases (CDAD) (September 2006)

Protocol Creutzfeldt-Jakob Disease (CJD) (November 2001)

Protocol Cryptosporidiosis (July 2013)

Protocol Cyclosporiasis (March 2016) NEW

Protocol Diphtheria (November 2001)

Protocol Ebola Virus Disease (EVD) Interim Protocol (March 2015) REVISED

See also Ebola Virus Disease (EVD) Infection Prevention and Control Interim Guidelines (March 2015) REVISED
See also Ebola Virus Disease (EVD) Infection Prevention and Control Interim Guidelines for PreHospital Settings (April 2015) NEW
See also Ebola Virus Disease (EVD) Public Health Contact Management Interim Guidelines (September 2015) REVISED
See also Ebola Virus Disease (EVD) Public Health Contact Management Interim Guidelines (September 2015) REVISED
See also Ebola Virus Disease (EVD) Environmental Cleaning/Disinfection Guidelines for Community Settings (February 2015) NEW

Protocol Interim Protocol for Handling Human Remains Infected with Ebola Virus (September 2015) NEW

Protocol Enteric Illness Protocol (March 2008)

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Protocol Giardiasis (September 2013)

Protocol Gonorrhea (August 2015) REVISED

LEGEND:  P = Protocol | L = LinkProtocol Haemophilus influenzae Disease (October 2007)

Protocol Hantavirus Pulmonary Syndrome (August 2015) REVISED

Protocol Hepatitis A (February 2014) REVISED

Protocol Hepatitis B (July 2013)
         See also:

Protocol Hepatitis B Newborn Prophylaxis Protocols (July 2013)
Protocol Integrated Post-Exposure Protocol for HIV, HBV and HCV: Guidelines for Managing Exposures to Blood and Body Fluids (March 2009)
Link Sexually Transmitted and Bloodborne Infections

Protocol Hepatitis C (December 2014) REVISED

         See also:
Protocol Integrated Post-Exposure Protocol for HIV, HBV and HCV: Guidelines for Managing Exposures to Blood and Body Fluids (March 2009)
Link Sexually Transmitted and Bloodborne Infections

Protocol Herpes Zoster (Shingles) (June 2014)

Protocol Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) (February 2010)
         See also:

Protocol Integrated Post-Exposure Protocol for HIV, HBV and HCV: Guidelines for Managing Exposures to Blood and Body Fluids (March 2009)
Link Sexually Transmitted and Bloodborne Infections

LEGEND:  P = Protocol | L = LinkProtocol Seasonal Influenza (September 2015) REVISED
         See also:

See also Seasonal Flu (The Flu) (July 2012)

Protocol Invasive Meningococcal Disease (Neisseria meningitidis)
(June 2011)

See also Meningococcal Post Exposure Prophylaxis Invoicing Process (April 2013)

Protocol Invasive Pneumococcal Disease (Streptococcus pneumoniae) (Pneumococcus)
(January 2011)

Protocol Legionellosis (revised March 2015)

Protocol Leprosy (November 2001)

Protocol Listeriosis (June 2011)        

Protocol Lyme Disease (revised February 2013)

Protocol Lymphogranuloma Venereum (LGV) (May 2007)

Protocol Malaria (November 2001)

Protocol Measles (Rubeola) (July 2010)

Methicillin and Vancomycin Resistant Staphylococcus aureus (MRSA/VRSA) Infection
        See:

Protocol Manitoba Guidelines for the Prevention and Control of Antibiotic Resistant Organisms (AROs) (January 2007)

Protocol Mumps (July 2010)

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Protocol Pediculosis Capitis (Head Lice) (July 2014)

Protocol Pertussis/Parapertussis (November 2007)

Protocol Plague (November 2001)
         See also:

Protocol Poliovirus Infections (November 2001)

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Protocol Q Fever (Coxiella burnetii) (April 2016) NEW

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Protocol Rabies:  Protocol for Management of Human Rabies and Management of Animal Exposures to Prevent Human Rabies (with April 2014 and January 2016 updates) REVISED

Protocol Rubella and Congenital Rubella Syndrome/Infection (November 2010)

LEGEND:  P = Protocol | L = LinkProtocol Salmonellosis (Non-Typhoid) (November 2011)

Protocol Seasonal Influenza (September 2015) REVISED

Protocol Sexually Transmitted Infections Treatment Guidelines
     The Sexually Transmitted Infections Treatment Guidelines have been archived. 
      Please refer to these disease specific protocols for treatment recommendations:

         See also:

Protocol Shigellosis (November 2011)

Protocol Streptococcal Disease (Group A Invasive) (November 2007)

Protocol Streptococcal (Group B) Disease of the Newborn (November 2001)

Protocol Syphilis (July 2014)
         See also:

Link Sexually Transmitted and Bloodborne Infections
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Protocol Tetanus (November 2001)

Link Travel Health (January 2015)

Protocol Manitoba Tuberculosis Protocol (February 2014) REVISED
  See also:

Link Manitoba Tuberculosis Program - Roles and Responsibilities Matrix (January 2014)

Protocol Tularemia: Information for Health Care Professionals (October 2004)

Protocol Typhoid and Paratyphoid Fever (Enteric Fever) (October 2012)

Vancomycin Resistant Enterococci (VRE)
         See:

Protocol Manitoba Guidelines for the Prevention and Control of
Antibiotic Resistant Organisms (AROs)
(January 2007)

Vancomycin Resistant Staphylococcus aureus
         See:

Protocol Manitoba Guidelines for the Prevention and Control of Antibiotic Resistant Organisms (AROs) (January 2007)

Protocol Varicella (Chickenpox) (June 2014) REVISED

Protocol Verotoxigenic Escherichia coli (VTEC) Infection (May 2007)

Protocol West Nile virus Public Health Human Case Investigation Protocol (July 2006)

Protocol Yellow Fever (November 2001)

Protocol Yersiniosis (February 2012)

Forms

Fact Sheets